BD Board Increases Dividend

FRANKLIN LAKES, N.J., Nov. 21, 2016

"We are extremely proud of our accomplishments during our first fiscal year as the 'new' BD.  We look forward to fiscal 2017 with confidence as we continue to focus on improving outcomes, expanding access to care, lowering costs and optimizing safety, which will ultimately enrich our purpose of advancing the world of health," said Vincent A. Forlenza, Chairman, CEO and President.  "This is the forty-fifth consecutive fiscal year in which we have raised our dividend.  This increase reflects our confidence in our long-term outlook, as well as our ongoing commitment to create value and return capital to our shareholders." 

About BD
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 40,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit bd.com.

Contact:
Kristen Cardillo, Corporate Communications – 201-847-5657
Monique Dolecki, Investor Relations – 201-847-5378

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bd-board-increases-dividend-300366764.html

SOURCE BD (Becton, Dickinson and Company)